In May 2025, South Sudan added the Pneumococcal Conjugate Vaccine (PCV) and Rotavirus Vaccine to its national routine immunization program. These vaccines protect against two leading causes of childhood illness and death. The introduction aimed to strengthen routine immunization services, improve service integration, and expand access to lifesaving interventions during the first year of life. The vaccines provide a "double shield" against pneumonia and severe diarrhoeal disease, which significantly contribute to under-five morbidity and mortality.

The Ministry of Health conducted a Post-Introduction Evaluation (PIE) with support from WHO, UNICEF, Gavi, and immunization partners. The evaluation examined implementation performance, operational challenges, and early program outcomes. It generated important lessons for sustaining vaccine delivery and improving immunization services nationwide. The PIE assessed how effectively the vaccines were integrated into routine immunization services.

Between May and November 2025, South Sudan conducted a nationwide PCV catch-up campaign targeting children aged 12–59 months. The campaign reached more than 2.2 million children and achieved approximately 88% administrative coverage. Post-campaign assessments documented over 83% coverage by vaccination card. The results demonstrated the program's ability to expand protection against pneumococcal disease rapidly.

The introduction of PCV and rotavirus vaccine represented an opportunity to strengthen routine immunization services and improve service integration. By introducing both vaccines through the infant immunization platform, South Sudan ensured that children could benefit from multiple preventive interventions during the same visit. This approach also strengthened the overall immunization system.

The evaluation demonstrates that successful vaccine introduction is not only about adding new antigens to the schedule but also about ensuring that the systems needed to deliver them reliably are strong enough to translate availability into protection. The Ministry of Health and its partners can use the lessons learned from the PIE to improve immunization services nationwide.

The PCV and rotavirus vaccine introduction is a significant step towards reducing childhood illness and death in South Sudan. Pneumonia and severe diarrhoeal disease are major causes of under-five morbidity and mortality. The vaccines will help protect children during the first year of life, a critical period for growth and development.

The Ministry of Health will continue to work with its partners to sustain vaccine delivery and improve immunization services. The successful introduction of PCV and rotavirus vaccine is a testament to the country's commitment to protecting its children and improving their health outcomes.

Key points

  • The introduction of PCV and rotavirus vaccine provides a "double shield" against pneumonia and severe diarrhoeal disease.
  • The Post-Introduction Evaluation (PIE) generated important lessons for sustaining vaccine delivery and improving immunization services nationwide.
  • The nationwide PCV catch-up campaign reached more than 2.2 million children and achieved approximately 88% administrative coverage.

Reporting sources

Share this story

Written by

SaharaWire Newsroom
SaharaWire

Reporting for SaharaWire from the Nairobi bureau.